Moderna Inc (MRNA)

Exchange
NASDAQ
Symbol
MRNA
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Country
USA

Stock price

At close: February 6, 2026

  • Open
    41.18
  • High
    41.49
  • Low
    39.50
  • Close
    41.01
  • Volume
    8,332,350

Financial ratios

Dec 31, 2024